Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
0% from low
Exchange
OTC Link
OS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2015 | 2016 | 2017 | 2018 | |
|---|---|---|---|---|
| Revenue | $13.0K | $266.9K | $14.8M | $16.7M |
| Cost of revenue | $5.0K | $171.9K | $16.7M | $20.7M |
| Gross profit | $8.0K | $95.0K | −$1.9M | −$4.1M |
| Gross margin | 61.8% | 35.6% | -12.8% | -24.3% |
| R&D | $0 | $102.9K | $467.4K | $80.5K |
| Operating income | −$1.9M | −$2.6M | −$18.1M | −$29.2M |
| EBITDA | −$6.7M | −$2.6M | −$26.9M | −$84.5M |
| Net income | −$6.7M | −$3.2M | −$27.9M | −$90.3M |
| Net margin | -51697.6% | -1204.1% | -188.2% | -542.1% |
| EPS (diluted) | -4.53 | -1.01 | -1.33 | -2.35 |
Annual figures · source: Financial Modeling Prep
ISODIOL INTERNATIONAL INC
No one on the platform currently holds ISOLF.
No tracked institution reports a position in ISOLF as of their last filing.
| Execution date | Ratio |
|---|---|
| 2018-07-24 | 1-for-10reverse |
No one on the platform has traded ISOLF yet.
| $56821 |
| — |
| HENCHero Technologies Inc. | $0.00 | +0.00% | $55269 | — |
| INSDInstadose Pharma Corp. | $0.00 | +0.00% | $53193 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.